EVEXIAZ

Welcome to the Brand page for “EVEXIAZ”, which is offered here for Pharmaceutical preparations for the treatment and prevention of motion sickness; pharmaceutical preparations for the treatment and prevention of a craving; pharmaceutical preparations for the treatment and prevention of nausea; pharmaceutical preparations for the treatment and prevention of vomiting; pharmaceutical preparations for the treatment and prevention of substance dependence; pharmaceutical preparations for the treatment and prevention of anxiety; pharmaceutical preparations for the treatment and prevention of diseases, disorders, or conditions caused by an over-expression of substance p; pharmaceutical preparations for the treatment and prevention of diseases, disorders, or conditions caused by overstimulation of the neurokinin-1 (nk-1) receptor; pharmaceutical preparations for the treatment of gastroparesis; pharmaceutical preparations for the treatment of pruritus; pharmaceutical preparations for the treatment of atopic dermatitis; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of a behavioral stressor; pharmaceutical preparations for treating epidermal problems; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases;.

Its status is currently believed to be active. Its class is unavailable. “EVEXIAZ” is believed to be currently owned by “Vanda Pharmaceuticals Inc.”

Owner:
VANDA PHARMACEUTICALS INC.
Owner Details
Description:
Pharmaceutical preparations for the treatment and prevention of motion sickness; Pharmaceutical preparations for the treatment and prevention of a craving; Pharmaceutical preparations for the treatment and prevention of nausea; Pharmaceutical preparations for the treatment and prevention of vomiting; Pharmaceutical preparations for the treatment and prevention of substance dependence; Pharmaceutical preparations for the treatment and prevention of anxiety; Pharmaceutical preparations for the treatment and prevention of diseases, disorders, or conditions caused by an over-expression of substance P; Pharmaceutical preparations for the treatment and prevention of diseases, disorders, or conditions caused by overstimulation of the neurokinin-1 (NK-1) receptor; Pharmaceutical preparations for the treatment of gastroparesis; Pharmaceutical preparations for the treatment of pruritus; Pharmaceutical preparations for the treatment of atopic dermatitis; Pharmaceutical preparations for the treatment of pain; Pharmaceutical preparations for the treatment of a behavioral stressor; Pharmaceutical preparations for treating epidermal problems; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases;
Categories: PHARMACEUTICAL PREPARATIONS TREATMENT